| P50 | author | Tiziana Rubino | Q56613336 |
| P2093 | author name string | Matthew N Hill | |
| | Daniel T Malone | |
| P2860 | cites work | Cannabis and psychiatric disorders: it is not only addiction | Q22242611 |
| | Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people | Q24558606 |
| | Cannabinoid receptor localization in brain | Q24558751 |
| | Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology | Q24602238 |
| | CB2 receptors in the brain: role in central immune function | Q24643895 |
| | Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning | Q24650912 |
| | High-potency cannabis and the risk of psychosis | Q24651025 |
| | Brain development during childhood and adolescence: a longitudinal MRI study | Q28144698 |
| | Role of endogenous cannabinoids in synaptic signaling | Q28185075 |
| | Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review | Q28215767 |
| | Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review | Q28238516 |
| | Structure of a cannabinoid receptor and functional expression of the cloned cDNA | Q28240076 |
| | Causal association between cannabis and psychosis: examination of the evidence | Q28241735 |
| | Adverse health effects of non-medical cannabis use | Q28261715 |
| | Identification and functional characterization of brainstem cannabinoid CB2 receptors | Q28276972 |
| | Cannabis and schizophrenia. A longitudinal study of Swedish conscripts | Q28283322 |
| | Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia | Q28285577 |
| | Molecular characterization of a peripheral receptor for cannabinoids | Q28298338 |
| | Enzymatic pathways that regulate endocannabinoid signaling in the nervous system | Q28390932 |
| | Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study | Q29615905 |
| | The adolescent brain and age-related behavioral manifestations | Q29618654 |
| | Determination and characterization of a cannabinoid receptor in rat brain | Q29618888 |
| | The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis | Q30047193 |
| | Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain | Q30047898 |
| | Gestational methylazoxymethanol acetate administration: a developmental disruption model of schizophrenia | Q30478274 |
| | Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies | Q30484459 |
| | Effect of social isolation on CB1 and D2 receptor and fatty acid amide hydrolase expression in rats | Q30489165 |
| | Development of cannabinoid 1 receptor protein and messenger RNA in monkey dorsolateral prefrontal cortex | Q30494037 |
| | Cannabidiol reverses the reduction in social interaction produced by low dose Delta(9)-tetrahydrocannabinol in rats | Q33435013 |
| | The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia | Q33679799 |
| | Genetic and non-genetic vulnerability factors in schizophrenia: the basis of the "two hit hypothesis". | Q33813156 |
| | Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use. | Q43581230 |
| | Autoradiographic study of pre- and postnatal distribution of cannabinoid receptors in human brain | Q43798328 |
| | The hypothalamic levels of the endocannabinoid, anandamide, peak immediately before the onset of puberty in female rats | Q43908958 |
| | Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study | Q44182591 |
| | Early-onset cannabis use and cognitive deficits: what is the nature of the association? | Q44360031 |
| | Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain. | Q44444709 |
| | Testing hypotheses about the relationship between cannabis use and psychosis | Q44487800 |
| | Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats | Q44530990 |
| | Reduced binocular depth inversion in regular cannabis users | Q44574413 |
| | Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia | Q44748286 |
| | Cannabis use and psychosis: a longitudinal population-based study. | Q44820509 |
| | Role of the endogenous cannabinoid system as a modulator of dopamine transmission: implications for Parkinson's disease and schizophrenia | Q44865127 |
| | Cannabidiol increases Fos expression in the nucleus accumbens but not in the dorsal striatum | Q44906750 |
| | Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms | Q45049153 |
| | Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats | Q45176520 |
| | Altered brain tissue composition in heavy marijuana users | Q45193430 |
| | Trends in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999. | Q45247994 |
| | Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood | Q45779424 |
| | Synthetic delta-9-tetrahydrocannabinol (dronabinol) can improve the symptoms of schizophrenia. | Q46013619 |
| | Cannabis use in children and adolescents with first episode psychosis: influence on psychopathology and short-term outcome (CAFEPS study). | Q46019528 |
| | The depressive phenotype induced in adult female rats by adolescent exposure to THC is associated with cognitive impairment and altered neuroplasticity in the prefrontal cortex | Q46041526 |
| | Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis | Q46066555 |
| | Early maternal deprivation induces gender-dependent changes on the expression of hippocampal CB(1) and CB(2) cannabinoid receptors of neonatal rats. | Q46179690 |
| | Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC). | Q46188729 |
| | Marijuana: use among young males and health outcomes | Q46224428 |
| | Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia | Q46370479 |
| | Gender-dependent cellular and biochemical effects of maternal deprivation on the hippocampus of neonatal rats: a possible role for the endocannabinoid system | Q46455764 |
| | The effect of Delta9-tetrahydrocannabinol on sensorimotor gating in socially isolated rats | Q46688133 |
| | Behavioral effects in adult rats of chronic prepubertal treatment with the cannabinoid receptor agonist WIN 55,212-2. | Q46691546 |
| | Chronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates. | Q46825379 |
| | Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol | Q33900859 |
| | Adolescent cannabis use, psychosis and catechol-O-methyltransferase genotype in African Americans and Caucasians | Q33925455 |
| | Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia | Q33932087 |
| | Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study | Q33962711 |
| | Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug | Q33995048 |
| | Hippocampal abnormalities and memory deficits: new evidence of a strong pathophysiological link in schizophrenia | Q34002498 |
| | Schizophrenia as a disorder of neurodevelopment | Q34132313 |
| | Nonpsychotropic cannabinoid receptors regulate microglial cell migration. | Q34179008 |
| | Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor | Q34245130 |
| | Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction | Q34415424 |
| | Cannabidiol reverses MK-801-induced disruption of prepulse inhibition in mice | Q34438163 |
| | CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms. | Q34504178 |
| | Effects of frequent marijuana use on brain tissue volume and composition | Q34507628 |
| | Brain morphological changes and early marijuana use: a magnetic resonance and positron emission tomography study | Q34508346 |
| | Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective | Q34509505 |
| | Tests of causal linkages between cannabis use and psychotic symptoms | Q34555395 |
| | Cannabis use and psychotic disorders: an update | Q34555939 |
| | Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis | Q34589855 |
| | Regional brain abnormalities associated with long-term heavy cannabis use. | Q34592700 |
| | Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression | Q34609936 |
| | Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use. | Q34708753 |
| | Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme | Q34721779 |
| | Stress, sensitive periods and maturational events in adolescent depression | Q34760313 |
| | Cannabinoid receptors: where they are and what they do. | Q34772274 |
| | Youth risk behavior surveillance--United States, 2007. | Q34784855 |
| | Effects of cannabis use on outcomes of psychotic disorders: systematic review | Q34870543 |
| | A preliminary DTI study showing no brain structural change associated with adolescent cannabis use. | Q34880461 |
| | Role of cannabis and endocannabinoids in the genesis of schizophrenia | Q34993855 |
| | Brain cannabinoid CB2 receptor in schizophrenia | Q35014134 |
| | Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal volume and asymmetry | Q35677987 |
| | Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies | Q35774562 |
| | Adolescent brain development: a period of vulnerabilities and opportunities. Keynote address | Q35835571 |
| | How antipsychotics become anti-"psychotic"--from dopamine to salience to psychosis | Q35847108 |
| | Is the party over? Cannabis and juvenile psychiatric disorder: the past 10 years | Q35894468 |
| | Endocannabinoid signaling system and brain reward: emphasis on dopamine | Q36152336 |
| | First-episode psychosis: psychopathology, quality of life, and functional outcome | Q36188449 |
| | Impact of substance use on the onset and course of early psychosis | Q36273889 |
| | Cannabinoids and prefrontal cortical function: insights from preclinical studies | Q36436004 |
| | A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data | Q36441017 |
| | Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder? | Q36517227 |
| | The emerging functions of endocannabinoid signaling during CNS development. | Q36707633 |
| | Item response theory analysis of DSM-IV cannabis abuse and dependence criteria in adolescents | Q36744255 |
| | Relationship of catechol-O-methyltransferase to schizophrenia and its correlates: evidence for associations and complex interactions | Q36965866 |
| | Endocannabinoid functions controlling neuronal specification during brain development | Q37131370 |
| | Leptin receptor deficiency is associated with upregulation of cannabinoid 1 receptors in limbic brain regions | Q37136294 |
| | Cannabis, cannabinoids and schizophrenia: integration of the evidence | Q37160448 |
| | The cognitive neuroscience of memory function and dysfunction in schizophrenia | Q37169856 |
| | Wiring and firing neuronal networks: endocannabinoids take center stage | Q37272835 |
| | Altered white matter microstructure in adolescent substance users | Q37325687 |
| | Prefrontal cortex morphometry in abstinent adolescent marijuana users: subtle gender effects | Q37341421 |
| | Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects | Q37349953 |
| | Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons. | Q38322450 |
| | Prevalence and correlates of past-year substance use, abuse, and dependence in a suburban community sample of high-school students | Q39674159 |
| | Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study | Q39680990 |
| | Hardwiring the brain: endocannabinoids shape neuronal connectivity | Q39798626 |
| | Changing incidence of psychotic disorders among the young in Zurich | Q40193848 |
| | Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales | Q40233735 |
| | Reduced binocular depth inversion as an indicator of cannabis-induced censorship impairment | Q41132462 |
| | Preferential limbic expression of the cannabinoid receptor mRNA in the human fetal brain | Q42440191 |
| | Behavioural disturbances and altered Fos protein expression in adult rats after chronic pubertal cannabinoid treatment | Q42446801 |
| | Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness | Q43406707 |
| | Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception | Q43511723 |
| | The association between early cannabis use and psychotic-like experiences in a community adolescent sample | Q43534322 |
| | Localization of mRNA expression and activation of signal transduction mechanisms for cannabinoid receptor in rat brain during fetal development. | Q47812684 |
| | Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. | Q48063516 |
| | Adolescent rats find repeated Delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure | Q48131076 |
| | Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine | Q48286778 |
| | Presence of cannabinoid binding sites in the brain from early postnatal ages | Q48335987 |
| | An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition | Q48435557 |
| | Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar longlasting deficits in object recognition and reduced social interaction in rats | Q48446296 |
| | The effects of an early stressful life event on sensorimotor gating in adult rats. | Q48468623 |
| | Recent-onset schizophrenia and adolescent cannabis use: MRI evidence for structural hyperconnectivity? | Q48508827 |
| | Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia | Q48532654 |
| | The effect of chronic peripubertal cannabinoid treatment on deficient object recognition memory in rats after neonatal mPFC lesion | Q48552353 |
| | Ultrastructural localization of neuronal brain CB2 cannabinoid receptors. | Q48837860 |
| | Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study | Q48881901 |
| | Neuroimaging of marijuana smokers during inhibitory processing: a pilot investigation | Q48952162 |
| | Different effects of nabilone and cannabidiol on binocular depth inversion in Man. | Q51080370 |
| | Sex differences in the effects of delta9-tetrahydrocannabinol on spatial learning in adolescent and adult rats. | Q51739846 |
| | Long-term effects of developmental PCP administration on sensorimotor gating in male and female rats. | Q51779948 |
| | Corpus callosum damage in heavy marijuana use: preliminary evidence from diffusion tensor tractography and tract-based spatial statistics. | Q51891740 |
| | Cannabis use and brain structural alterations in first episode schizophrenia--a region of interest, voxel based morphometric study. | Q51894564 |
| | Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use. | Q51902545 |
| | Early adolescent cannabis exposure and positive and negative dimensions of psychosis. | Q51937432 |
| | Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. | Q51982139 |
| | A community survey of adverse effects of cannabis use. | Q52006749 |
| | Psychotic reactions following cannabis use in East Indians. | Q52117018 |
| | The ontogeny of cannabinoid receptors in the brain of postnatal and aging rats. | Q52211667 |
| | Cannabis and psychosis: two kinds of limitations which attach to epidemiological research | Q52286020 |
| | The disruption of prepulse inhibition by social isolation in the Wistar rat: how robust is the effect? | Q52530694 |
| | A Total Synthesis of dl-Δ1-Tetrahydrocannabinol, the Active Constituent of Hashish1 | Q55970558 |
| | Symptoms of schizotypy precede cannabis use | Q56768431 |
| | Association of cannabis use with prodromal symptoms of psychosis in adolescence | Q56906218 |
| | Cannabis use and age of diagnosis of schizophrenia | Q57602685 |
| | Schizotypy and psychosis-like experiences from recreational cannabis in a non-clinical sample | Q59599152 |
| | Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system. | Q64996366 |
| | Cannabis induced psychosis | Q71048435 |
| | Elevated endogenous cannabinoids in schizophrenia | Q73029596 |
| | The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies | Q73553209 |
| | A clinical and metabolic study of acute intoxication with Cannabis sativa and its role in the model psychoses | Q78517764 |
| | Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study | Q78822220 |
| | A population based elaboration of the role of age of onset on the course of schizophrenia | Q80235261 |
| | Endogenous cannabinoids: structure and metabolism | Q95801320 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | epidemiology | Q133805 |
| | psychosis | Q170082 |
| | teenager | Q1492760 |
| P304 | page(s) | 511-522 | |
| P577 | publication date | 2010-06-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models | |
| P478 | volume | 160 | |